These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26267517)

  • 1. Activating Mutations in PIK3CA Lead to Widespread Modulation of the Tyrosine Phosphoproteome.
    Zahari MS; Wu X; Blair BG; Pinto SM; Nirujogi RS; Jelinek CA; Malhotra R; Kim MS; Park BH; Pandey A
    J Proteome Res; 2015 Sep; 14(9):3882-3891. PubMed ID: 26267517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations.
    Blair BG; Wu X; Zahari MS; Mohseni M; Cidado J; Wong HY; Beaver JA; Cochran RL; Zabransky DJ; Croessmann S; Chu D; Toro PV; Cravero K; Pandey A; Park BH
    Proteomics; 2015 Jan; 15(2-3):318-26. PubMed ID: 25367220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs.
    Ross RL; Askham JM; Knowles MA
    Oncogene; 2013 Feb; 32(6):768-76. PubMed ID: 22430209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
    Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of diverse signalling pathways by oncogenic PIK3CA mutations.
    Wu X; Renuse S; Sahasrabuddhe NA; Zahari MS; Chaerkady R; Kim MS; Nirujogi RS; Mohseni M; Kumar P; Raju R; Zhong J; Yang J; Neiswinger J; Jeong JS; Newman R; Powers MA; Somani BL; Gabrielson E; Sukumar S; Stearns V; Qian J; Zhu H; Vogelstein B; Park BH; Pandey A
    Nat Commun; 2014 Sep; 5():4961. PubMed ID: 25247763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Cigarette Smoke Mediated Global Changes in Lung Mucoepidermoid Cells: A Phosphoproteomic Analysis.
    Solanki HS; Advani J; Khan AA; Radhakrishnan A; Sahasrabuddhe NA; Pinto SM; Chang X; Prasad TSK; Mathur PP; Sidransky D; Gowda H; Chatterjee A
    OMICS; 2017 Aug; 21(8):474-487. PubMed ID: 28816646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways.
    Carvalho CR; Carvalheira JB; Lima MH; Zimmerman SF; Caperuto LC; Amanso A; Gasparetti AL; Meneghetti V; Zimmerman LF; Velloso LA; Saad MJ
    Endocrinology; 2003 Feb; 144(2):638-47. PubMed ID: 12538627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteome analyses identify PrfA-responsive proteins and phosphoproteins in Listeria monocytogenes.
    Misra SK; Moussan Désirée Aké F; Wu Z; Milohanic E; Cao TN; Cossart P; Deutscher J; Monnet V; Archambaud C; Henry C
    J Proteome Res; 2014 Dec; 13(12):6046-57. PubMed ID: 25383790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of major ERK-related phosphorylation sites in Gab1.
    Lehr S; Kotzka J; Avci H; Sickmann A; Meyer HE; Herkner A; Muller-Wieland D
    Biochemistry; 2004 Sep; 43(38):12133-40. PubMed ID: 15379552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade.
    Wang C; Che L; Hu J; Zhang S; Jiang L; Latte G; Demartis MI; Tao J; Gui B; Pilo MG; Ribback S; Dombrowski F; Evert M; Calvisi DF; Chen X
    Liver Int; 2016 Aug; 36(8):1176-86. PubMed ID: 26716908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global redox proteome and phosphoproteome analysis reveals redox switch in Akt.
    Su Z; Burchfield JG; Yang P; Humphrey SJ; Yang G; Francis D; Yasmin S; Shin SY; Norris DM; Kearney AL; Astore MA; Scavuzzo J; Fisher-Wellman KH; Wang QP; Parker BL; Neely GG; Vafaee F; Chiu J; Yeo R; Hogg PJ; Fazakerley DJ; Nguyen LK; Kuyucak S; James DE
    Nat Commun; 2019 Dec; 10(1):5486. PubMed ID: 31792197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations.
    Hafner C; Landthaler M; Vogt T
    Exp Dermatol; 2010 Aug; 19(8):e222-7. PubMed ID: 20557351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
    Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
    J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival.
    Hartmann W; Küchler J; Koch A; Friedrichs N; Waha A; Endl E; Czerwitzki J; Metzger D; Steiner S; Wurst P; Leuschner I; von Schweinitz D; Buettner R; Pietsch T
    Clin Cancer Res; 2009 Jul; 15(14):4538-45. PubMed ID: 19584164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.
    Polzer H; Janke H; Schmid D; Hiddemann W; Spiekermann K
    Exp Hematol; 2013 Mar; 41(3):271-80.e4. PubMed ID: 23127761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
    Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research resource: identification of novel growth hormone-regulated phosphorylation sites by quantitative phosphoproteomics.
    Ray BN; Kweon HK; Argetsinger LS; Fingar DC; Andrews PC; Carter-Su C
    Mol Endocrinol; 2012 Jun; 26(6):1056-73. PubMed ID: 22570334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
    Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K
    Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.